Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients
Kohei Kaku
Expert Opinion on Drug Safety (2017) Vol. 16, Iss. 11, pp. 1313-1322
Closed Access | Times Cited: 15

Showing 15 citing articles:

Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders
Deepthi Ramesh, Balaji Gowrivel Vijayakumar, Tharanikkarasu Kannan
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112801-112801
Closed Access | Times Cited: 56
Synthesis and clinical application of representative small-molecule dipeptidyl Peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus (T2DM)
Dong-Wei Shao, Zhao Lijie, Jinfeng Sun
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116464-116464
Closed Access | Times Cited: 7
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Bassam M. Ayoub, Shereen Mowaka, Marwa M. Safar, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Design, Synthesis, and Evaluation of a Series of Novel Super Long-Acting DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
Chen Zhang, Fei Ye, Jianmin Wang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 13, pp. 7108-7126
Closed Access | Times Cited: 38
Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes
Shiliang Li, Chun Qin, Shichao Cui, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 5, pp. 2348-2361
Closed Access | Times Cited: 26
Trelagliptin stimulates osteoblastic differentiation by increasing runt-related transcription factor 2 (RUNX2): a therapeutic implication in osteoporosis
Haiyu Shao, Renzheng Wu, Li Cao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 960-968
Open Access | Times Cited: 20
Uracil: A Pharmacophore with Diverse Biological Potential
Kashish Jain, Shivali Sharma, Divya Utreja
ChemistrySelect (2024) Vol. 9, Iss. 5
Closed Access | Times Cited: 1
A biweekly DPP‐4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial
Qinghua He, Zhifeng Cheng, Yufeng Li, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 965-975
Closed Access | Times Cited: 1
Novel Synthesis, Docking studies and Antitumor Evaluation of Pyrazolo- and Pyrazolo Aminophosphonate Derivatives Derived from N-Heterocyclic Amines
Maha D. Khidre, Fatma Abdelaleem, Sherifa Abu Bakr, et al.
Egyptian Journal of Chemistry (2022)
Open Access | Times Cited: 6
Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants
Qing Li, Xiaoyan Deng, Yan‐Jun Xu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 11593-11631
Closed Access | Times Cited: 2
Different Spectrophotometric Methods for Simultaneous Determination of Trelagliptin and Its Acid Degradation Product
Shereen Mowaka, Bassam M. Ayoub, Mostafa Afifi Hassan, et al.
Journal of Analytical Methods in Chemistry (2018) Vol. 2018, pp. 1-7
Open Access | Times Cited: 4
Development of a Divergent Synthesis Strategy for 5-Sulfonyl-Substituted Uracil Derivatives
Lukas von Bredow, Alexander Fürll, Maik Tretbar
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 21, pp. 15990-15994
Open Access
The anti-diabetic drug trelagliptin induces vasodilation via activation of Kv channels and SERCA pumps
Ryeon Heo, Mi Seon Seo, Jin Ryeol An, et al.
Life Sciences (2021) Vol. 283, pp. 119868-119868
Closed Access | Times Cited: 2
Investigation of Pharmacokinetic Parameters of Trelagliptin in Egyptian Volunteers Using Sensitive LC-MS/MS: A Comparative Study with a Japanese Population
Shereen Mowaka, Nermeen Ashoush, Mariam M. Tadros, et al.
Journal of Analytical Methods in Chemistry (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 2
The Efficacy and Tolerability of Sitagliptin, Saxagliptin, Vildagliptin, Lindagliptin, Alogliptin, Omarigliptin and Trelagliptin in Patients with Type 2 Diabetes: Protocol for a Network Meta-Analysis of Randomized Control Trials
Guoquan Chen, Jiale Chen, Xiaoxia Hu, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top